Asan Medical Center
Seoul, 138-736, South Korea
NCT Number: NCT00945516
The purpose of this study is to determine the feasibility, easy removability, safety, and migration rate of flared end fully covered self-expanding metal stent (FCSEMS) and anchoring FCSEMS for benign biliary stricture.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 3
Seoul, 138-736, South Korea
Benign biliary strictures (BBS) are usually managed with plastic stents, whereas placement of uncovered metallic stents has been associated with failure related to mucosal hyperplasia. Fully covered self-expanding metal stent(FCSEMS) placement was reported as a useful method for BBS. However, stent migration was a frequent complication of CSEMS placement. Recently, flared end FCSEMS was developed to decrease stent migration, and anchoring CSEMS was newly developed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flared end FCSEMS for benign bile duct stricture will be inserted with ERCP.
Other names: Bona stent® (Sewoon medical Co., LTD., Seoul, Korea)
Anchoring FCSEMS for benign bile duct stricture will be inserted with ERCP.
Other names: Hanarostent® (M.I.Tech, Seoul, Korea)
Time frame: one year
Time frame: one year
Time frame: one year
Time frame: one year
Asan Medical Center
Other
Newly Designed Fully Covered Metal Stent for the Benign Biliary Stricture: Prospective Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04185363
Bile Duct Diseases, Biliary Tract Diseases
Los Angeles, California, United States
View Trial DetailsNCT04729751
Abnormalities, Multiple, Alagille Syndrome
Los Angeles, California, United States
View Trial DetailsNCT06364865
Acute Cholecystitis, Appendix
Miami, Florida, United States
View Trial DetailsNCT05263752
Bile Duct Diseases, Biliary Tract Diseases
Dallas, Texas, United States
View Trial Details